Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-04 4:08 pm Purchase |
2021-06-16 | 13D | 23andMe Holding Co. ME |
GSK PLC | 1,983,024 13.200% |
1,983,024 (New Position) |
Filing History |
| 2022-09-20 4:12 pm Sale |
2022-09-16 | 13D | Theravance Biopharma, Inc. TBPH |
GSK PLC | 0 0.000% |
-9,644,807 (Position Closed) |
Filing History |
| 2022-08-03 08:33 am Unchanged |
2022-08-03 | 13D | Theravance Biopharma, Inc. TBPH |
GSK PLC | 9,644,807 12.700% |
0 (Unchanged) |
Filing History |
| 2022-07-27 4:24 pm Purchase |
2022-07-17 | 13D | Haleon plc HLN |
GSK PLC | 1,195,320,110 12.940% |
1,195,320,110 (New Position) |
Filing History |
| 2022-05-13 4:14 pm Unchanged |
2022-04-28 | 13D | Nkarta, Inc. NKTX |
GSK PLC | 3,161,432 6.800% |
0 (Unchanged) |
Filing History |
| 2022-02-14 1:31 pm Purchase |
2021-12-31 | 13G | GSK plc GSK |
Dodge & Cox | 94,377,360 5.900% |
94,377,360 (New Position) |
Filing History |
| 2022-02-10 4:55 pm Purchase |
2021-12-31 | 13G | Genocea Biosciences, Inc. GNCA |
GSK PLC | 5,861,389 9.900% |
644,000 (+12.34%) |
Filing History |
| 2022-02-10 4:51 pm Purchase |
2021-12-31 | 13G | Lyell Immunopharma, Inc. LYEL |
GSK PLC | 30,253,189 12.600% |
30,253,189 (New Position) |
Filing History |
| 2022-02-10 4:50 pm Sale |
2021-12-31 | 13G | F-star Therapeutics, Inc. FSTX |
GSK PLC | 802,627 3.900% |
-1,295 (-0.16%) |
Filing History |
| 2022-02-10 4:48 pm Unchanged |
2021-11-08 | 13D | Theravance Biopharma, Inc. TBPH |
GSK PLC | 9,644,807 13.100% |
0 (Unchanged) |
Filing History |
| 2022-02-10 4:46 pm Purchase |
2021-12-31 | 13G | Vir Biotechnology, Inc. VIR |
GSK PLC | 8,550,954 6.500% |
1,924,927 (+29.05%) |
Filing History |
| 2022-02-07 4:40 pm Purchase |
2021-12-31 | 13G | GSK plc GSK |
BlackRock Inc. BLK |
314,663,473 7.800% |
12,836,062 (+4.25%) |
Filing |
| 2021-09-27 06:01 am Unchanged |
2021-08-16 | 13G | Fulcrum Therapeutics, Inc. FULC |
GSK PLC | 1,785,714 4.500% |
0 (Unchanged) |
Filing History |
| 2021-09-16 5:27 pm Unchanged |
2021-08-05 | 13D | Spero Therapeutics, Inc. SPRO |
GSK PLC | 1,740,606 5.400% |
0 (Unchanged) |
Filing History |
| 2021-09-16 5:22 pm Sale |
2021-08-05 | 13D | Bicycle Therapeutics plc BCYC |
GSK PLC | 1,529,561 6.000% |
-86,734 (-5.37%) |
Filing History |
| 2021-07-12 4:52 pm Purchase |
2021-07-02 | 13G | CVRx, Inc. CVRX |
GSK PLC | 1,007,583 5.000% |
1,007,583 (New Position) |
Filing History |
| 2021-05-25 4:24 pm Sale |
2021-05-20 | 13D | Innoviva, Inc. INVA |
GSK PLC | 0 0.000% |
-32,005,260 (Position Closed) |
Filing History |
| 2021-04-16 4:17 pm Sale |
2021-04-09 | 13D | Bicycle Therapeutics plc BCYC |
GSK PLC | 1,616,295 7.000% |
-278,536 (-14.70%) |
Filing History |
| 2021-04-08 5:24 pm Sale |
2021-04-01 | 13D | PANDION THERAPEUTICS INC PAND |
GSK PLC | 0 0.000% |
-2,262,301 (Position Closed) |
Filing History |
| 2021-02-12 5:13 pm Unchanged |
2021-02-12 | 13D | Innoviva, Inc. INVA |
GSK PLC | 32,005,260 31.600% |
0 (Unchanged) |
Filing History |